v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (215.0) $ (106.1)
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion and amortization 313.7 328.9
Amortization of acquired unfavorable contracts (7.6) (39.1)
Stock-based compensation 6.6 6.1
Loss (gain) on insurance recoveries 0.3 (3.2)
Loss (gain) on disposal of assets, net 14.1 (2.5)
Non-cash loss on extinguishment of debt   0.8
Amortization of debt issuance costs 8.9 11.2
Loss (gain) on investments, net 6.8 0.9
Provision for supply commitment charges   9.6
Provision for credit losses, net of recoveries 12.8  
Goodwill impairment   74.5
Deferred tax benefit (16.5) (25.4)
Other non-cash items, net 0.4 (0.1)
Changes in operating assets and liabilities:    
Accounts receivable 26.4 13.4
Inventories 24.1 26.7
Prepaid expenses and other assets (7.3) (15.0)
Accounts payable (23.3) 24.3
Accrued expenses 9.5 7.0
Other liabilities (13.9) (21.2)
Net cash provided by operating activities 140.0 290.8
Cash flows from investing activities:    
Acquisitions, net of cash acquired   (194.4)
Investment in property, plant & equipment (133.3) (191.8)
Proceeds from sale of assets 4.9 31.9
Proceeds from insurance recoveries   4.5
Other 0.4 (2.0)
Net cash used in investing activities (128.0) (351.8)
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 38.5 136.4
Repayments of long-term debt (103.7) (110.0)
Borrowings from revolving credit agreements 1,344.3 1,580.4
Repayments of revolving credit agreements (1,324.6) (1,540.6)
Payment of debt issuance costs (0.6) (3.5)
Cash settlement of vested stock awards (1.2)  
Tax withholding related to net share settlement of equity awards   (1.5)
Proceeds from issuance of common stock 82.4  
Payment of common stock issuance costs (3.4)  
Other (0.5)  
Net cash provided by financing activities 31.2 61.2
Net increase in cash, cash equivalents, and restricted cash 43.2 0.2
Cash, cash equivalents, and restricted cash beginning of period 14.8 25.3
Cash, cash equivalents, and restricted cash end of period 58.0 25.5
Non-cash investing and financing activities    
Capital expenditures included in accounts payable 10.0 38.2
Operating lease liabilities incurred from obtaining right-of-use assets 1.0 55.7
Finance lease liabilities incurred from obtaining property, plant & equipment $ 1.9 $ 9.9

Source

PDF HTML 10-Q Filing
ZIP HTML XBRL